biokitHSV-2 Rapid Test, REF: 300028001 — FDA record Z-1021-2023

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Sep 28, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
biokitHSV-2 Rapid Test, REF: 300028001
Reason
HSV-2 rapid test may report false positive results.
Classification
Class II
Recalling firm
Biokit, S.A.
Quantity
2,393
Agency-reported status
Ongoing
Source record identifier
Z-1021-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI-DI/Lots - Expiration Dates: 08426951056439/ B34243 - 2022-09-30, B34309 - 2022-11-30, B34463 - 2022-11-30, B34465 - 2023-02-28, B35052 - 2023-05-31, B35188 - 2023-07-31, B35398 - 2023-10-31

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide distribution in the states of NY, CA, IN, NC, VA.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Feb 1, 2023
Recall initiation date
Sep 28, 2022
Center classification date
Jan 26, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records